171 related articles for article (PubMed ID: 37957796)
1. New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study.
Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
Allergy Asthma Immunol Res; 2023 Nov; 15(6):795-811. PubMed ID: 37957796
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.
Bali V; Schelfhout J; Sher MR; Tripathi Peters A; Patel GB; Mayorga M; Goss D; Romano CD
Ther Adv Respir Dis; 2024; 18():17534666241236025. PubMed ID: 38501735
[TBL] [Abstract][Full Text] [Related]
3. Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study.
Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
Ther Adv Respir Dis; 2023; 17():17534666231167716. PubMed ID: 37078383
[TBL] [Abstract][Full Text] [Related]
4. Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis.
Domingo C; Fernandez M; Garin N; Milara J; Moran I; Muerza I; Pacheco A; Teruel C; Bentley R; Subiran R; Gil A
Appl Health Econ Health Policy; 2023 Jan; 21(1):119-130. PubMed ID: 36319945
[TBL] [Abstract][Full Text] [Related]
5. Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough?
Sundar KM; Stark AC; Hu N; Barkmeier-Kraemer J
ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33816599
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study.
Dávila I; Puente L; Quirce S; Arismendi E; Díaz-Palacios M; Pereira-Vega A; de Diego A; Rodriguez-Hermosa JL; Cea-Calvo L; Sánchez-Jareño M; López-Cotarelo P; Domingo C
Lung; 2023 Jun; 201(3):275-286. PubMed ID: 37160771
[TBL] [Abstract][Full Text] [Related]
7. A register-based study: cough - a frequent phenomenon in the adult population.
Backer V; Porsborg A; Hansen V; Skjold T; Schmid JM; Kehlet M; Torp-Pedersen C; Aasbjerg K
BMC Pulm Med; 2022 Nov; 22(1):426. PubMed ID: 36401236
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant.
Morice AH; Birring SS; Smith JA; McGarvey LP; Schelfhout J; Martin Nguyen A; Xu ZJ; Wu WC; Muccino DR; Sher MR
Lung; 2021 Apr; 199(2):121-129. PubMed ID: 33825965
[TBL] [Abstract][Full Text] [Related]
9. Speech and language therapy for management of chronic cough.
Slinger C; Mehdi SB; Milan SJ; Dodd S; Matthews J; Vyas A; Marsden PA
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD013067. PubMed ID: 31335963
[TBL] [Abstract][Full Text] [Related]
10. Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
Dicpinigaitis PV; Birring SS; Blaiss M; McGarvey LP; Morice AH; Pavord ID; Satia I; Smith JA; La Rosa C; Li Q; Nguyen AM; Schelfhout J; Tzontcheva A; Muccino D
Ann Allergy Asthma Immunol; 2023 Jan; 130(1):60-66. PubMed ID: 35569802
[TBL] [Abstract][Full Text] [Related]
11. Systematic literature review of treatments used for refractory or unexplained chronic cough in adults.
Bali V; Kardos P; Page C; Rogliani P; Calzetta L; Adriano A; Byrne A; Adeyemi A; Frederickson A; Schelfhout J
Ann Thorac Med; 2024; 19(1):56-73. PubMed ID: 38444993
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough.
Mazzone SB; McGarvey L
Clin Pharmacol Ther; 2021 Mar; 109(3):619-636. PubMed ID: 32748976
[TBL] [Abstract][Full Text] [Related]
13. Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough.
Muccino DR; Morice AH; Birring SS; Dicpinigaitis PV; Pavord ID; Assaid C; Kleijn HJ; Hussain A; La Rosa C; McGarvey L; Smith JA
ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33263037
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report.
Gibson P; Wang G; McGarvey L; Vertigan AE; Altman KW; Birring SS;
Chest; 2016 Jan; 149(1):27-44. PubMed ID: 26426314
[TBL] [Abstract][Full Text] [Related]
15. Understanding physician's knowledge and perception of chronic cough in Switzerland.
Leuppi JD; Guggisberg P; Koch D; Favre-Bulle A; Fabiani M; Heinz S; Zeller A
Curr Med Res Opin; 2022 Aug; 38(8):1459-1466. PubMed ID: 35369836
[TBL] [Abstract][Full Text] [Related]
16. Can clinical characteristics differentiate patients with unexplained chronic cough from patients with asthma and COPD?
Singh U; Bernstein JA
Allergy Asthma Proc; 2023 Mar; 44(2):90-99. PubMed ID: 36872445
[No Abstract] [Full Text] [Related]
17. Quantitative measurement properties and score interpretation of the Cough Severity Diary in patients with chronic cough.
Martin Nguyen A; Bacci E; Dicpinigaitis P; Vernon M
Ther Adv Respir Dis; 2020; 14():1753466620915155. PubMed ID: 32345170
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and predictors of response to inhaled corticosteroid treatment for chronic cough.
Hong JY; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
Korean J Intern Med; 2019 May; 34(3):559-568. PubMed ID: 30540903
[TBL] [Abstract][Full Text] [Related]
19. Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough.
Muccino D; Green S
Pulm Pharmacol Ther; 2019 Jun; 56():75-78. PubMed ID: 30880151
[TBL] [Abstract][Full Text] [Related]
20. Burden of refractory and unexplained chronic cough on patients' lives: a cohort study.
Puente-Maestu L; Dávila I; Quirce S; Crespo-Lessmann A; Martínez-Moragón E; Sola J; Nieto ML; González-Barcala FJ; Cea-Calvo L; Sánchez-Jareño M; Rivas-Pardinas C; Domingo C
ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37753282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]